Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Basal Cell Carcinoma”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Very early researchLooking for participantsNCT05651828
What this trial is testing

Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma

Who this might be right for
Advanced Basal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 34
Post-approval studies (Phase 4)Study completedNCT03610022
What this trial is testing

Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1

Who this might be right for
Metastatic Basal Cell CarcinomaLocally Advanced Basal Cell Carcinoma
University Hospital, Bordeaux 27
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableStudy completedNCT02371967
What this trial is testing

Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC)

Who this might be right for
Basal Cell Carcinoma
Hoffmann-La Roche 50
Early research (Phase 1)Study completedNCT04323202
What this trial is testing

Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N

Who this might be right for
Basal Cell Carcinoma of the Head and Neck
Case Comprehensive Cancer Center 13
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)UnknownNCT04806646
What this trial is testing

Tailored Sonidegib Schedule After Complete Response in BCC

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Gruppo Oncologico del Nord-Ovest 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT06357988
What this trial is testing

Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm+3 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT03897036
What this trial is testing

Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)

Who this might be right for
Carcinoma, Basal Cell
Senhwa Biosciences, Inc. 25
Testing effectiveness (Phase 2)Looking for participantsNCT05929664
What this trial is testing

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Who this might be right for
Locally Advanced Basal Cell CarcinomaBasal Cell Carcinoma
Thomas Jefferson University 70
Not applicableStudy completedNCT07068568
What this trial is testing

Dose-Modulated Sonidegib Therapy for Periocular Basal Cell Carcinoma

Who this might be right for
Basal Cell CancerEyelid TumorBasal Cell Carcinoma (BCC)+1 more
Federico II University 12
Early research (Phase 1)Study completedNCT00023959
What this trial is testing

Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+51 more
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Study completedNCT01327053
What this trial is testing

A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Novartis Pharmaceuticals 230
Post-approval studies (Phase 4)Study completedNCT06880848
What this trial is testing

Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China

Who this might be right for
Carcinoma, Basal Cell (BCC)
Jemincare 160
Early research (Phase 1)Study completedNCT01204073
What this trial is testing

TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies

Who this might be right for
Advanced Nonhematologic MalignanciesCarcinoma, Basal Cell
Millennium Pharmaceuticals, Inc. 34
Not applicableStudy completedNCT01529450
What this trial is testing

Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors

Who this might be right for
Basal Cell Carcinoma
Anne Chang 11
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Load More Results